- CleanTech agreed to sell the Robinson-Lasher zinc-germanium-gallium project to Silver Elephant Mining under a transaction involving cash, shares and exploration commitments.
- The disclosed consideration included 6.3 million Silver Elephant shares, deemed at C$0.13 each and described as approximately 9.9% of Silver Elephant on a pro-forma basis, plus US$1.255 million of staged cash payments.
- The transaction combined cash, shares and buyer spending commitments rather than a single cash purchase price.
The development
CleanTech signed an asset purchase agreement to sell its Robinson-Lasher zinc-germanium-gallium project in Nevada to Silver Elephant Mining.
The disclosed consideration included 6.3 million Silver Elephant shares, deemed at C$0.13 each and described as approximately 9.9% of Silver Elephant on a pro-forma basis, plus US$1.255 million of staged cash payments.
Silver Elephant also agreed to minimum exploration expenditures of US$2 million and preparation of a technical report, subject to the detailed transaction terms and required approvals.
CleanTech framed the divestiture as a way to concentrate management and capital on its fluorspar portfolio. Director John Lee, who had an interest in both companies, abstained from the relevant CleanTech board approval.
Why this matters
The proposed sale narrows CleanTech's portfolio and directs more attention toward fluorspar while retaining equity exposure to the buyer.
The practical significance depends on follow-through in later filings, technical reports or operating updates rather than the announcement alone.
Industry and company context
The transaction combined cash, shares and buyer spending commitments rather than a single cash purchase price.
This article was added during the August 6, 2026 archive review and preserves the announcement date so the $CTV timeline remains chronological.
How to evaluate the update
The core facts to evaluate are the quantified terms, dates and conditions disclosed in the source. The transaction combined cash, shares and buyer spending commitments rather than a single cash purchase price.
Readers should separate completed actions from targets, proposed transactions, management expectations and other forward-looking statements.
Execution and risk considerations
Closing and future value depend on approvals, buyer performance, share-price movements and completion of the staged obligations.
Forward-looking statements, estimates and management expectations can change; readers should use later company filings and technical disclosure for current status.
What to watch next
- Closing of the asset sale and required approvals.
- Receipt of staged cash and share consideration.
- Silver Elephant's exploration spending and technical report.
- CleanTech capital allocation after the divestiture.
Cornerstone perspective
The proposed sale narrows CleanTech's portfolio and directs more attention toward fluorspar while retaining equity exposure to the buyer. The most useful evidence now is the next verifiable milestone rather than the headline in isolation.
Cornerstone will treat later source documents as controlling where they supersede the June 12, 2026 disclosure.
Source review
This report was checked against the linked primary issuer, newswire or regulatory source and independently cross-checked against a second public-market, newswire or regulatory record during the August 6, 2026 editorial review.
Figures, dates, transaction status and forward-looking conditions are stated conservatively; later disclosure controls where it supersedes the original announcement.
This article is informational and is not investment advice or a recommendation to buy or sell securities. Forward-looking statements involve risks and uncertainty. Readers should review the original source and report factual concerns through our corrections page.
